Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
659 studies found for:    Vaginal Diseases: Clinical Trials
Show Display Options
RSS Create an RSS feed from your search for:
Vaginal Diseases: Clinical Trials
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Trial Evaluating the Safety of a Lactate Releasing Vaginal Ring for the Prophylaxis of Bacterial Vaginosis
Condition: Vaginosis, Bacterial
Intervention: Device: Vaginal ring releasing lactic acid (racemic mixture)
2 Completed Bacterial Vaginosis; A Randomized Trial to Reduce Recurrence
Condition: Bacterial Vaginosis
Interventions: Other: hygienic information plus 62% ethyl alcohol in emollient gel;   Other: hygienic information
3 Completed
Has Results
Recurrent Bacterial Vaginosis and Vaginal Acidifying Gel Trial
Condition: Bacterial Vaginosis
Interventions: Drug: Vaginal acidifying gel (RepHresh);   Drug: Metronidazole control
4 Recruiting Safety and Efficacy of 5% Monolaurin Vaginal Gel Administered Intravaginally for the Treatment of Bacterial Vaginosis
Condition: Bacterial Vaginosis
Interventions: Drug: 5% Monolaurin Vaginal Gel;   Other: Placebo
5 Recruiting Randomized Controlled Trial of Treatment of Male Partners of Women With BV
Condition: Recurrent Bacterial Vaginosis
Interventions: Drug: Metronidazole (male partner);   Other: Placeob (male partner)
6 Completed Trial of Trimosan Gel Effect on Pessary-associated Bacterial Vaginosis
Condition: Bacterial Vaginosis
Intervention: Drug: Trimo-San gel
7 Completed Lcr35® for Bacterial Vaginosis Prevention
Condition: Bacterial Vaginosis
Interventions: Drug: placebo;   Drug: Lcr35®
8 Completed Rwanda VMB Restoration Study
Condition: Bacterial Vaginosis
Interventions: Biological: Vaginal probiotics for prevention of BV recurrence (Ecologic Femi vaginal capsule);   Drug: Prophylactic use of metronidazole pills (500 mg);   Biological: Vaginal probiotics for prevention of BV recurrence (Gynophilus vaginal tablet)
9 Recruiting LACTIN-V Study for Recurrent Bacterial Vaginosis
Condition: Bacterial Vaginosis
Interventions: Biological: Lactobacillus crispatus CTV-05;   Drug: Metronidazole;   Other: Placebo
10 Completed Prevention of Very Preterm Delivery by Testing for and Treatment of Bacterial Vaginosis
Condition: Pregnancy
Interventions: Drug: Clindamycin;   Drug: Placebo
11 Terminated Efficacy Study of Preconception Treatment of an Asymptomatic Bacterial Infection in an Infertility Population
Conditions: Vaginosis, Bacterial;   Infertility;   Miscarriage
Interventions: Drug: Metronidazole;   Drug: Placebo
12 Completed
Has Results
A Clinical Study to Evaluate Ospemifene in the Treatment of Vulvar and Vaginal Atrophy in Postmenopausal Women
Conditions: Atrophy;   Vaginal Diseases
Interventions: Drug: Ospemifene 30 mg;   Drug: Ospemifene 60 mg;   Drug: Placebo;   Drug: Nonhormonal vaginal lubricant
13 Completed
Has Results
A Clinical Study to Evaluate the Efficacy and Safety of Ospemifene in the Treatment of Vulvar and Vaginal Atrophy (VVA) in Postmenopausal Women
Conditions: Atrophy;   Vaginal Diseases
Interventions: Drug: Placebo;   Drug: Ospemifene 5 mg;   Drug: Ospemifene 15 mg;   Drug: Ospemifene 30 mg
14 Completed
Has Results
A Clinical Study to Evaluate the Safety of Ospemifene
Conditions: Atrophy;   Vaginal Diseases
Interventions: Drug: Ospemifene 60 mg;   Drug: Placebo
15 Completed
Has Results
Efficacy and Safety of Ospemifene in the Treatment of Moderate to Severe Vaginal Dryness and Vaginal Pain Associated With Sexual Activity
Conditions: Atrophy;   Vaginal Diseases
Interventions: Drug: Ospemifene 60 mg;   Drug: Placebo;   Drug: Non-hormonal vaginal lubricant
16 Completed
Has Results
Long-Term Safety of Ospemifene 60 mg Oral Daily Dose for the Treatment of Vulvar and Vaginal Atrophy (VVA) in Postmenopausal Women Without a Uterus
Conditions: Atrophy;   Vaginal Diseases
Intervention: Drug: Ospemifene
17 Completed
Has Results
Long-Term Safety of 30 mg and 60 mg Oral Daily Dose of Ospemifene in the Treatment of Vulvar and Vaginal Atrophy (VVA) in Postmenopausal Women With Intact Uterus
Conditions: Atrophy;   Vaginal Diseases
Interventions: Drug: Ospemifene (Dose 1);   Drug: Ospemifene (Dose 2);   Drug: Placebo
18 Unknown  Probiotic Versus Placebo as Adjuvant for Bacterial Vaginosis Treatment During Pregnancy
Condition: Bacterial Vaginosis
Interventions: Drug: Lactobacillus acidophilus;   Drug: Placebo
19 Terminated Probiotics for the Prevention of Premature Birth and Neonatal Related Morbidity
Conditions: Bacterial Vaginosis;   Premature Birth;   Sepsis;   Periventricular Leukomalacia;   Bronchopulmonary Dysplasia
Intervention: Drug: Lactobacillus rhamnosus GR1 and Lactobacillus reuteri RC-14
20 Completed Effect of a Yoghurt Containing Four Probiotic Lactobacillus Strains on Bacterial Vaginosis
Condition: Bacterial Vaginosis
Interventions: Other: probiotic yoghurt;   Other: chemically acidified milk;   Drug: Arilin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.